Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iluvit pilot study of intravitreal fluocinolone acetonide in chronic diabetic macular edema
2016-004488-38Phase 4Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluocinolone in diabetic macular edema (DME), sponsored by Goethe University Frankfurt. Primary endpoint: Posterior vitreous IL-6 concentration. Started Aug 2017; status: completed.
02
Drugs
fluocinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2016-004488-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004488-38.